A Clinical Trial Worth Considering
Yale University in Connecticut is conducting a very interesting phase II clinical trial on a drug called Phenoxodiol for men with castrate and noncastrate prostate cancer. Phenoxodiol has been undergoing trials in Australia with promising results. The good news is that most men do not seem to have any negative side effects from the drug. [...]
